BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 19527098)

  • 1. Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?
    Menzin J; Lines LM; Marton J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):257-64. PubMed ID: 19527098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costs of smoking and the cost effectiveness of smoking-cessation programs.
    Elixhauser A
    J Public Health Policy; 1990; 11(2):218-37. PubMed ID: 2114423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The health benefits of smoking cessation for adult smokers and for pregnant women in Taiwan.
    Wen CP; Cheng TY; Lin CL; Wu HN; Levy DT; Chen LK; Hsu CC; Eriksen MP; Yang HJ; Tsai SP
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i56-61. PubMed ID: 15923451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determining the possibility of collecting reliable data for use in decision making in health care on the example of cost-effectiveness analysis of methods used in smoking cessation].
    Bała M
    Przegl Lek; 2004; 61(10):1180-3. PubMed ID: 15794284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The total lifetime health cost savings of smoking cessation to society.
    Rasmussen SR; Prescott E; Sørensen TI; Søgaard J
    Eur J Public Health; 2005 Dec; 15(6):601-6. PubMed ID: 16014659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands.
    Vemer P; Rutten-van Mölken MP; Kaper J; Hoogenveen RT; van Schayck CP; Feenstra TL
    Addiction; 2010 Jun; 105(6):1088-97. PubMed ID: 20659063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
    Thavorn K; Chaiyakunapruk N
    Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the health benefits of smoking cessation in Japan.
    Avila-Tang E; Apelberg BJ; Yamaguchi N; Katanoda K; Sobue T; Samet JM
    Tob Control; 2009 Feb; 18(1):10-7. PubMed ID: 18728096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression.
    Barnett PG; Wong W; Hall S
    Addiction; 2008 May; 103(5):834-40. PubMed ID: 18412763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of smoking cessation programmes and a smoking ban in public places: comparing gain in life expectancy and cost effectiveness.
    Højgaard B; Olsen KR; Pisinger C; Tønnesen H; Gyrd-Hansen D
    Scand J Public Health; 2011 Dec; 39(8):785-96. PubMed ID: 21976052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The health care costs of smoking.
    Barendregt JJ; Bonneux L; van der Maas PJ
    N Engl J Med; 1997 Oct; 337(15):1052-7. PubMed ID: 9321534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-benefit analysis of smoking cessation programs during the first trimester of pregnancy for the prevention of low birthweight.
    Hueston WJ; Mainous AG; Farrell JB
    J Fam Pract; 1994 Oct; 39(4):353-7. PubMed ID: 7931114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purchasing health insurance coverage for smoking cessation treatment: employers describe the most influential information in this decision.
    Woolf NH; Burns ME; Bosworth TW; Fiore MC
    Nicotine Tob Res; 2006 Dec; 8(6):717-25. PubMed ID: 17132519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical review of the arguments for insurance coverage for smoking-cessation therapies.
    Chang CF
    Manag Care; 2001 May; 10(5):62-5. PubMed ID: 11392730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in health care costs before and after smoking cessation.
    Fishman PA; Thompson EE; Merikle E; Curry SJ
    Nicotine Tob Res; 2006 Jun; 8(3):393-401. PubMed ID: 16801297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of full coverage of the medical management of smoking cessation in France.
    Chevreul K; Cadier B; Durand-Zaleski I; Chan E; Thomas D
    Tob Control; 2014 May; 23(3):223-30. PubMed ID: 23197369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health focus: effectiveness of smoking-control strategies--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Sep; 41(35):645-7, 653. PubMed ID: 1508130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular benefits of smoking cessation.
    Gottlieb SO
    Heart Dis Stroke; 1992; 1(4):173-5. PubMed ID: 1344104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities.
    Godtfredsen NS; Prescott E
    Clin Respir J; 2011 Oct; 5(4):187-94. PubMed ID: 21689381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.